The collaboration aims to empower patients in Malaysia to take control of their health by launching a digital therapeutics platform that focuses on three key therapeutic areas namely smoking cessation, vaccination, and heart health.
The financial burden that comes along with cancer is high, forcing some patients to take their medication irregularly so that they don’t have to purchase new medication so soon.
The majority of Covid-19 patients with chronic kidney disease and chronic pulmonary disease except asthma had severe Covid-19 disease at 58% and 53% respectively.